Grindr Inc. entered into a definitive agreement to sell approximately 3.7 million non-voting junior shares held indirectly by its controlling shareholder to PurposeMed, a private medical group. This transaction, valued at $69,705,000, is intended to advance medical diagnostics capabilities and reduce related-party holdings.